Emerging evidence demonstrates CTSS promotes NF-κB activation in autoimmune encephalomyelitis, hepatitis, periodontitis, and hyperglycemia-induced endothelial inflammation (19, 29, 84). This evidence concerns the gene NFKB1 and Hepatitis.